American Regent, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 960 Crupper Avenue, Columbus, Ohio (OH) 43229, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 3003433784 · DUNS 116981917
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-03-05
- NAIDrug Quality Assurance2021-11-19
- NAIDrug Quality Assurance2017-11-15
- NAIDrug Quality Assurance2017-03-09
- VAIDrug Quality Assurance2014-08-08
- NAIDrug Quality Assurance2013-04-11
- VAIDrug Quality Assurance2012-02-07
- VAIDrug Quality Assurance2009-06-26
Drugs this plant is listed as making
9 distinct drugs across 18 products name this site in their FDA label.
- Betamethasone Sodium Phosphate and Betamethasone AcetateAmerican Regent, Inc.
- Chlorothiazide SodiumAmerican Regent, Inc.
- Estradiol ValerateAmerican Regent, Inc.
- Ferric CarboxymaltoseAmerican Regent, Inc.
- Ferric Carboxymaltose InjectionAmerican Regent, Inc.
- fomepizoleAmerican Regent, Inc.
- iron sucroseAmerican Regent, Inc.
- nicardipine hydrochlorideAmerican Regent, Inc.
- tranexamic acidAmerican Regent, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.